For the first time, a marijuana-based medication approved by federal regulators is available for prescription in the United States.
The medication, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological illness, according to a news release.
“Because these patients have not responded well to available seizure drugs, there was a dire need for new treatments that aim to decrease the frequency and impact of seizures,” said Justin Gover, chief executive officer of GW Pharmaceuticals, the United Kingdom-based company that developed the drug, in a statement.
Read the rest of this story on DenverPost.com.
